Mounjaro Lawsuit Canada — Were You Seriously Harmed?
Canadians who experienced gastroparesis, bowel obstruction, or other serious side effects after taking Mounjaro may qualify for a free legal case review. Get answers today.
- Free, no-obligation case review
- No fees unless your case settles
- All Canadian provinces and territories
13
Provinces & territories served
100%
Free case review
0
Upfront fees
Free Case Review — No Obligation
Find Out If You Qualify
Answer a few quick questions. It takes about 2 minutes.
Step 1 of 3
What Is Mounjaro and Why Are People Filing Claims?
Mounjaro (tirzepatide) is a dual GLP-1 and GIP receptor agonist approved by Health Canada for the management of type 2 diabetes in adults. It works by mimicking two key hormones that regulate blood sugar, appetite, and stomach emptying. In recent years, it has been increasingly prescribed off-label for weight loss and metabolic control.
While Mounjaro has been effective for many patients, a significant number of users in Canada and elsewhere have reported serious gastrointestinal complications — including gastroparesis (delayed gastric emptying), bowel obstruction, severe nausea, and vomiting requiring medical intervention. These side effects can persist even after discontinuing the medication, significantly impacting quality of life.
Legal proceedings are underway in Canada and the United States, with individuals alleging that Eli Lilly and Company, the manufacturer of Mounjaro, failed to adequately warn prescribers and patients about these risks. Canadian cases are in varying stages of development and eligibility requirements apply.
Mounjaro Side Effects That May Qualify
These are the most commonly reported serious side effects in current Mounjaro legal inquiries. If you experienced one or more of these after taking Mounjaro, you may qualify.
Gastroparesis
A condition where the stomach cannot empty itself normally, causing nausea, vomiting, bloating, and severe abdominal pain. GLP-1 medications slow gastric motility and have been linked to gastroparesis.
Stomach Paralysis
Closely related to gastroparesis, stomach paralysis refers to the stomach's inability to contract and move food into the small intestine. It can cause serious nutritional complications.
Bowel Obstruction
Reports of ileus (temporary bowel paralysis) and bowel obstruction have emerged in patients using GLP-1 medications. These can be life-threatening without prompt treatment.
Vision Loss
Emerging research has associated GLP-1 receptor agonists with non-arteritic anterior ischemic optic neuropathy (NAION), a serious condition that can cause irreversible vision loss.
Severe GI Symptoms
Beyond gastroparesis, some patients report severe nausea, vomiting, diarrhea, and abdominal pain that required hospitalization or led to significant weight loss and malnutrition.
Other Serious Effects
Pancreatitis, kidney injury, and other serious complications have also been reported. If you experienced a serious adverse event after taking a GLP-1 medication, you may qualify.
Mounjaro Lawsuit FAQ
Common questions about Mounjaro injury claims in Canada.
Mounjaro (tirzepatide) is a GLP-1 and GIP receptor agonist originally developed for type 2 diabetes management. It has been associated with serious gastrointestinal side effects including gastroparesis, bowel obstruction, severe nausea, vomiting, and other adverse events that may require hospitalization.
Mounjaro received Health Canada approval for type 2 diabetes management. Despite regulatory approval, serious adverse events have been reported. If you believe Mounjaro caused your injury due to inadequate warnings, you may have grounds for a legal claim.
Yes. Mounjaro was originally approved for type 2 diabetes, and injury claims can arise regardless of the indication for which you were prescribed the medication. What matters is whether you experienced a serious side effect after taking Mounjaro.
Both Mounjaro and Foundayo contain tirzepatide as the active ingredient. They are the same medication marketed under different brand names or for different purposes. If you took either Mounjaro or Foundayo, your situation would be evaluated similarly as a tirzepatide-related injury claim.
Ready to Find Out If You Qualify?
The Mounjaro case review process is free, confidential, and carries no obligation. If you believe Mounjaro caused your injury, get started now.
- You took Ozempic, Wegovy, or another GLP-1 medication
- You experienced a serious side effect
- You are a resident of Canada
- You have not yet retained a lawyer for this matter
Free case review · No obligation · No upfront fees
Important Legal Notice
GLP-1 Justice is not a law firm and does not provide legal advice. Submitting information through this site does not create an attorney–client relationship. Information submitted may be shared with licensed legal service providers for case review.
The information on this website is provided for general informational purposes only and does not constitute legal advice. No lawyer–client relationship is formed by submitting information through this site or by calling any phone number listed herein.
Individual results vary. Past outcomes are not indicative of future results. Qualifying for a case review does not guarantee a legal claim exists or will succeed. All legal claims are subject to applicable limitation periods and other legal requirements.
This site is intended for residents of Canada only. Services may not be available in all provinces or territories.